A detailed history of Cwm, LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 273 shares of PSTX stock, worth $2,579. This represents 0.0% of its overall portfolio holdings.

Number of Shares
273
Previous 233 17.17%
Holding current value
$2,579
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$2.7 - $4.04 $108 - $161
40 Added 17.17%
273 $1,000
Q2 2024

Jul 09, 2024

BUY
$2.0 - $3.46 $466 - $806
233 New
233 $1,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $811M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.